EUVIMEDEUVIMED entdecken
Crossref

The need for a second transurethral resection in high‐risk non‐muscle‐invasive bladder cancer based on the Vesicle Imaging–Reporting and Data System

Yuki Nakamura iD, Soichiro Yoshida iD, Yuki Arita iD, Ryo Takeshita, Koichiro Kimura iD, Masaki Kobayashi iD, Motohiro Fujiwara iD, Yudai Ishikawa iD, Shohei Fukuda iD, Yuma Waseda iD, Hajime Tanaka iD, Masahiro Jinzaki iD und 1 weitere

International Journal of Urology · 2025-03 · 32 (3) · 264-269

DOI: 10.1111/iju.15638 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Urology, online erschienen am 09.12.2024. Verfasst von Yuki Nakamura und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Institute of Science Tokyo, Tokyo, Japan. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Neoplasm Recurrence, Local, Cystectomy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The efficacy of Vesical Imaging–Reporting and Data System (VI‐RADS) for the second transurethral resection (TUR) has not been adequately validated. This study aimed to evaluate the utility of the VI‐RADS for high‐risk patients with non‐muscle‐invasive bladder cancer (NMIBC) who are candidates for a second TUR.

Methods

We retrospectively analyzed 116 patients who received magnetic resonance imaging (MRI) prior to an initial TUR and underwent a second TUR for a diagnosis of high‐risk NMIBC at the initial TUR. MRI images were retrospectively classified according to VI‐RADS. Second TUR outcomes and recurrence‐free and progression‐free survival rates were compared with VI‐RADS scores.

Results

Ninety‐nine (91%) patients were diagnosed with T1 bladder cancer at the initial TUR. At the second TUR, residual cancer was found in 53 (49%) cases, including five (4.6%) cases of muscle invasion. With a median follow‐up of 41 months, the 2‐year bladder recurrence‐free survival rate was 71% and the 2‐year progression‐free rate was 85%. By two radiologists' consensus, 30 (28%)/49 (45%)/16 (15%)/10 (9.2%)/4 (3.7%) cases were classified as VI‐RADS 1/2/3/4/5, respectively. Of five pT2 upstage cases, three were VI‐RADS 1, one was VI‐RADS 2, and one was VI‐RADS 3. There was no significant association between VI‐RADS and cancer residual rate and pT2 upstage rate in second TUR outcomes, and recurrence‐free and progression‐free survival rates.

Conclusion

In high‐risk NMIBCs, a certain number of residual cancers and pT2 upstage cases exist after the initial TUR, and a second TUR should be performed regardless of VI‐RADS scores.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsNeoplasm Recurrence, LocalCystectomyHumansMaleRetrospective StudiesFemaleAgedMiddle AgedMagnetic Resonance ImagingAged, 80 and overNeoplasm InvasivenessUrinary BladderProgression-Free SurvivalReoperationNeoplasm, ResidualFollow-Up StudiesNeoplasm StagingNon-Muscle Invasive Bladder Neoplasms

Stichwörter der Autor:innen

Vesical Imaging–Reporting and Data Systemdiagnosismagnetic resonance imagingnon‐muscle‐invasive bladder cancertransurethral resection

Autor:innen und Institutionen

  • Department of Urology, Institute of Science Tokyo, Tokyo, Japan.
  • Department of Diagnostic Radiology, Keio University School of Medicine, Tokyo, Japan.
  • Department of Radiology, Sloan Kettering Institute, New York, New York, USA.
  • Department of Diagnostic Radiology, Institute of Science Tokyo, Tokyo, Japan.

ORCID-Profile: Yuki Nakamura, Soichiro Yoshida, Yuki Arita, Koichiro Kimura, Masaki Kobayashi, Motohiro Fujiwara, Yudai Ishikawa, Shohei Fukuda, Yuma Waseda, Hajime Tanaka, Masahiro Jinzaki, Yasuhisa Fujii

Zitieren

APA

Nakamura, Y., Yoshida, S., Arita, Y., Takeshita, R., Kimura, K., Kobayashi, M., Fujiwara, M., Ishikawa, Y., Fukuda, S., Waseda, Y., Tanaka, H., Jinzaki, M., & Fujii, Y. (2025). The need for a second transurethral resection in high‐risk non‐muscle‐invasive bladder cancer based on the Vesicle Imaging–Reporting and Data System. International Journal of Urology, 32(3), 264-269. https://doi.org/10.1111/iju.15638

Vancouver

Nakamura Y, Yoshida S, Arita Y, Takeshita R, Kimura K, Kobayashi M, et al. The need for a second transurethral resection in high‐risk non‐muscle‐invasive bladder cancer based on the Vesicle Imaging–Reporting and Data System. International Journal of Urology. 2025;32(3):264-269. doi:10.1111/iju.15638

BibTeX
@article{Nakamura2025,
  author = {Nakamura, Yuki and Yoshida, Soichiro and Arita, Yuki and Takeshita, Ryo and Kimura, Koichiro and Kobayashi, Masaki and Fujiwara, Motohiro and Ishikawa, Yudai and Fukuda, Shohei and Waseda, Yuma and Tanaka, Hajime and Jinzaki, Masahiro and Fujii, Yasuhisa},
  title = {The need for a second transurethral resection in high‐risk non‐muscle‐invasive bladder cancer based on the Vesicle Imaging–Reporting and Data System},
  journal = {International Journal of Urology},
  year = {2025},
  volume = {32},
  number = {3},
  pages = {264--269},
  doi = {10.1111/iju.15638}
}
Kostenlos starten →